Pre- and Post- COVID-19 Exposure Prophylaxis: Ep4 - Hematologic Malignancies

IMPACT Medicom

In this podcast series on pre- and post- COVID-19 prophylaxis, we discuss immunization against COVID-19 and how we can protect our most vulnerable populations who are not able to mount a sufficient antibody response to vaccination.
In this fourth episode of the series, we discuss:

• Response to COVID-19 vaccines in the general population
• Response to COVID-19 vaccines in immunocompromised people
• The impact of COVID-19 on patients with hematologic malignancies
• The potential role of pre- and post- COVID-19 exposure prophylaxis for people with hematologic malignancies

Our Guest:
Our guest on today’s episode is Dr. Carolyn Owen, who is an an Associate Professor in the Division of Hematology & Hematological Malignancies at the University of Calgary.
This podcast episode was sponsored by AstraZeneca Canada.

If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com